New Drug Applications

News Channels

News Archive

RSS Article Feeds

Subscribe to Newsletter

To get info on the latest products, specials and pharmacy news, please enter your e-mail address:

September 10th, 2009

Ceravix Receives Commendatory Advice From FDA Advisory Committee

GlaxoSmithKline recently advised the public that the US FDA’s Vaccines and Related Biological Products Advisory Committee voted that Ceravix, the company’s cervical cancer vaccine, presented data that substantiates the efficacy and safety of the treatment.

August 17th, 2009

Saphris Sublingual Tabs Receives FDA Endorsement

The US FDA has approved Saphris sublingual tablets for the acute therapy of schizophrenic adults, as well as the acute therapy of manic or mixed bipolar I disorder, with or without adult psychotic attributes. Saphris is endorsed for first-line therapy, and is the first prescription drug to receive primary consent for both of these symptoms concurrently.

August 6th, 2009